Table 7.
Impact index, standard error, risk index, p value, and 95% confidence intervals using the Cox model in conjunction with TCGA.
| Variable | Impact coefficient | Hazard ratio | Standard error | p value | 95% CI (RH) |
|---|---|---|---|---|---|
| Premenopausal | 1.35 | 3.8 | 3.168 | 0.66 | 7e − 03 (1.930e+03) |
| Luminal A | -1.05 | 0.34 | 4709 | 0.99 | 0 (Inf) |
| Luminal B | 1.64 | 0.19 | 4709 | 0.99 | 0 (Inf) |
| Stage II tumor | -0.97 | 0.37 | 2.89 | 0.73 | 1.294e − 03 (1.105e + 02) |
| Stage III tumor | -0.16 | 0.85 | 2.54 | 0.94 | 5.852e − 03 (1.238e + 02) |
| Stage IV tumor | -7.27 | 6.90E − 04 | 2.00E + 04 | 0.99 | 0(Inf) |
| Hormone receptor EP | -1.18 | 0.3 | 2.36 | 0.62 | 3.011e − 03 (3.132e + 01) |
| Hormone receptor other | -2.94 | 0.05 | 4709 | 0.99 | 0(Inf) |
| Hormone TN receptor | -2.67 | 0.07 | 4709 | 0.99 | 0 (Inf) |
| Age (54.70] | -0.48 | 0.61 | 3.75 | 0.89 | 3.871e − 04 (9.709e + 02) |
| Age (70,100] | 0.08 | 1.08 | 3.29 | 0.97 | 1.693e − 03 (7.004e + 02) |
| Nodal status (0.8] | 1.43 | 4.19 | 2.3 | 0.53 | 4.58e + 02 (3.83e + 02) |
| Nodal status (19.44] | 1.3 | 3.68 | 2.38 | 0.58 | 3.446e − 026 (3.931e + 02) |
| Nodal status (8.19] | 0.35 | 1.42 | 2.2 | 0.87 | 1.798e − 02 (1.132e + 02) |